Medications

Ketamine-based nasal spray to treat depression

The FDA recently approved a ketamine-based drug to assist with treating depression. The new medication, Spravato, is an intranasal spray that can help those suffering with extreme depression who see little results with psychiatric ...

Psychology & Psychiatry

Study reveals a new target for developing treatments for depression

A new CAMH study shows for the first time that people experiencing clinical depression have higher levels of a brain protein called MAO-B. The finding—published online today in JAMA Psychiatry - opens the door to a new ...

Psychology & Psychiatry

Integrated therapy treating obesity and depression is effective

An intervention combining behavioral weight loss treatment and problem-solving therapy with as-needed antidepressant medication for participants with co-occurring obesity and depression improved weight loss and depressive ...

Medications

BDNF–VEGF interplay key to rapid antidepressant actions

A study by researchers at Yale University reveals a complex interplay of two different growth factors in the rapid and long-lasting antidepressant effects of ketamine. The study, published in Biological Psychiatry, reports ...

Psychology & Psychiatry

Benzodiazepines may decrease mortality in congestive heart failure

A study published in the current issue of Psychotherapy and Psychosomatics indicates that treatment of anxiety with benzodiazepines may improve survival in congestive heart failure. Depression (in various forms and as various ...

Cardiology

A-fib risk up for antidepressant users, but higher before Tx

(HealthDay)—The risk for atrial fibrillation (AF) is increased among antidepressant users, particularly before treatment initiation, according to a study recently published in the European Journal of Preventive Cardiology.

page 1 from 23

Antidepressant

An antidepressant is a psychiatric medication used to alleviate mood disorders, such as major depression and dysthymia. Drugs including the monoamine oxidase inhibitors (MAOIs), tricyclic antidepressants (TCAs), tetracyclic antidepressants (TeCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin-norepinephrine reuptake inhibitors (SNRIs) are most commonly associated with the term. These medications are among those most commonly prescribed by psychiatrists and other physicians, and their effectiveness and adverse effects are the subject of many studies and competing claims. Many drugs produce an antidepressant effect, but restrictions on their use have caused controversy and off-label prescription a risk, despite claims of superior efficacy.

Most typical antidepressants have a delayed onset of action (2–6 weeks) and are usually administered for anywhere from months to years. Despite the name, antidepressants are often used to treat other conditions, such as anxiety disorders, obsessive compulsive disorder, eating disorders, chronic pain, and some hormone-mediated disorders such as dysmenorrhea. Alone or together with anticonvulsants (e.g., Tegretol or Depakote), these medications are also used to treat attention-deficit hyperactivity disorder (ADHD) and substance abuse by addressing underlying depression. Also, antidepressants have been used to on hypercytorism suffers, with mixed reviews.

Other medications that are not usually called antidepressants, including antipsychotics in low doses and benzodiazepines, may be used to manage depression, although benzodiazepines may cause physical dependence if treatment is not properly monitored by a doctor. Stopping benzodiazepine treatment abruptly can cause unpleasant withdrawal symptoms. An extract of the herb St John's Wort is commonly used as an antidepressant, although it is labeled as a dietary supplement in some countries. The term antidepressant is sometimes applied to any therapy (e.g., psychotherapy, electro-convulsive therapy, acupuncture) or process (e.g., sleep disruption, increased light levels, regular exercise) found to improve a clinically depressed mood.

Inert placebos can have significant antidepressant effects, and so to establish a substance as an "antidepressant" in a clinical trial it is necessary to show superior efficacy to placebo.

This text uses material from Wikipedia, licensed under CC BY-SA